Takeda Vietnam Pharmaceutical Limited Company secured the top spot in the "Best Workplaces in Vietnam 2026" ranking, small business category, as recognized by the global research and consulting firm Great Place To Work.
Great Place To Work compiled the ranking from an independent survey of over 111,000 employees nationwide. The survey assessed levels of trust, credibility, and overall workplace experience.
A Takeda Vietnam representative stated that inclusion on the Best Workplace list reflects the strength of its corporate culture and clear objectives. These values, rooted in trust, empower employees to develop capabilities, enhance work efficiency, and generate positive impacts for patients, the community, and the business.
 |
A Takeda Vietnam representative receives the Best Workplace 2026 award. *Photo: Great Place To Work.*
The company's operating philosophy combines heritage, core values, and performance. Takeda Vietnam enhances its corporate culture by strengthening employee engagement, streamlining work methods, and fostering a flexible environment.
Benjamin Ping, general director of Takeda Vietnam, stated that the recognition as a top workplace in Vietnam clearly reflects the company's people, values, and aspirations.
"We believe our team's potential and multi-generational commitment to innovation will positively impact patients, the community, and society", Ping said. "This recognition motivates us to continue building a workplace where everyone can develop, demonstrate their capabilities, and contribute to a healthier world for future generations."
 |
Takeda Vietnam employees at an annual meeting. *Photo: Takeda Vietnam.*
The corporate culture is embodied by the "Vietnamese Bamboo Leadership" philosophy, inspired by bamboo's resilience. The bamboo roots symbolize Takeda's core values, the trunk represents employee strength, and the branches signify innovative solutions for evolving healthcare needs.
 |
Takeda Vietnam collaborates with various organizations on community awareness initiatives for dengue fever. *Photo: Takeda Vietnam.*
Takeda demonstrates this commitment through its efforts in dengue fever prevention. Vietnam records an average of 100,000 dengue fever cases annually. Collaborating with health agencies and partners, Takeda supports an integrated prevention model, aiming for zero dengue fever deaths by 2030, aligned with WHO goals.
Takeda Vietnam also expands access to advanced medicines across several therapeutic areas: gastroenterology and inflammation, oncology, plasma-derived therapies, neurology, rare diseases, and vaccines. Concurrently, it enhances early diagnostic capabilities through public-private partnerships.
Established in Osaka, Japan, in 1781, Takeda has evolved over 245 years. The company focuses its research and development (R&D) efforts within the biopharmaceutical industry on six therapeutic areas: gastroenterology and inflammation, rare diseases, plasma-derived therapies, oncology, neurology, and vaccines.
The group's operating philosophy stems from a multi-generational commitment to reshaping healthcare. Globally, the company invests in capabilities, technology, and partnerships to accelerate research, improving speed and quality to deliver innovations to patients.
Yen Chi
